CD36 and fatty liver disease: In summary, we uncover that drinking‐water supplementation of D‐mannose serves as a candidate T2D therapeutic, which rescued hepatic steatosis and diabetic bone loss through suppressing macrophage release of EVs based on metabolic control of CD36 expression.